To support a feasibility study using a bi-partite assay cartridge as a multiplex diagnostic platform for the ultrasensitive detection and quantitation of unamplified nucleic acid targets of influenza A. This innovative system is designed to be compact, fast, and fully automated.

Agency
National Institute of Health (NIH)
Type
Small Business Innovation Research – Phase I (N43)
Project #
272201300027C-0-0-1
Application #
8745835
Study Section
Project Start
2013-09-30
Project End
2014-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$219,779
Indirect Cost
Name
Wave 80 Biosciences, Inc.
Department
Type
DUNS #
127755382
City
San Francisco
State
CA
Country
United States
Zip Code
94107